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ABSTRACT
We have sequenced miRNA libraries from human em-
bryonic, neural and foetal mesenchymal stem cells.
We report that the majority of miRNA genes en-
code mature isomers that vary in size by one or
more bases at the 3′ and/or 5′ end of the miRNA.
Northern blotting for individual miRNAs showed that
the proportions of isomiRs expressed by a single
miRNA gene often differ between cell and tissue
types. IsomiRs were readily co-immunoprecipitated
with Argonaute proteins in vivo and were active in
luciferase assays, indicating that they are functional.
Bioinformatics analysis predicts substantial differ-
ences in targeting between miRNAs with minor 5′
differences and in support of this we report that a 5′
isomiR-9–1 gained the ability to inhibit the expres-
sion of DNMT3B and NCAM2 but lost the ability to
inhibit CDH1 in vitro. This result was confirmed by
the use of isomiR-specific sponges. Our analysis of
the miRGator database indicates that a small per-
centage of human miRNA genes express isomiRs as
the dominant transcript in certain cell types and anal-
ysis of miRBase shows that 5′ isomiRs have replaced
canonical miRNAs many times during evolution. This
strongly indicates that isomiRs are of functional im-
portance and have contributed to the evolution of
miRNA genes.
INTRODUCTION
Gene expression is subject to extensive regulation by small
RNAs, which were first discovered in plants and inverte-
brates and have key roles in epigenetic regulation, gene tran-
scription andRNA silencing (1,2). The human genome con-
tains over 2000 genes that encodemiRNAs of 19 to 26 bases
in length that regulate most developmental and physiolog-
ical processes, including some pathological processes (3).
Mature miRNAs are processed from primary transcripts in
a two-step process involving the RNase III endonucleases
Drosha in the nucleus and Dicer in the cytoplasm, resulting
in a miRNA duplex consisting of the miRNA and a com-
plementary star miRNA (4,5). The miRNA or occasionally
the star miRNA is then bound within the RISC complex
(RNA-induced silencing complex) to one of fourArgonaute
proteins, in such a way that all of the miRNA sequence with
the exception of the very end bases, may anneal to target se-
quences (6).
MicroRNAs anneal to mRNAs that have complemen-
tary target sequences in order to effect RNA silencing, ei-
ther through the inhibition of RNA translation or by the
induction of mRNA degradation (7,8). However, examples
of miRNAs that enhance the translation of certain proteins
have also been found (9,10). Full complementarity between
the miRNA and its target sequence is not required for the
inhibition of translation although perfect complementarity
is often found to a seed sequence region from bases 2 to 7
of a substantial number of miRNAs (11,12).
A number of experimental analyses indicate that several
hundred mRNAs can be suppressed by a single miRNA.
The identification of key mRNA targets of individual miR-
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NAs is challenging and a number of genetic and biochemi-
cal approaches are being used to address this problem (13–
15). Programs such as targetscan (http://www.targetscan.
org) and targetscan custom (http://www.targetscan.org/
vert 50/seedmatch.html) that predict mRNA targets of
miRNAs are very helpful in this regard and are based upon
nucleic acid complementarity and other factors such as evo-
lutionary conservation of predictedmRNA target sites. Pre-
dictive programs currently use single miRNA sequences
listed in miRBase; however, many miRNAs are generated
as a family of related isomers that differ by a small num-
ber of bases at the 5′ and 3′ end of the miRNA, termed
5′ or 3′ isomiRs (16,17). IsomiRs are most probably gen-
erated by variation in processing by Drosha and/or Dicer
enzymes, although other processing enzymes may also be
involved (16). 5′isomiRs can in theory target different tran-
scripts compared to the canonical miRNA due to shifts in
the critical 5′ seed region from the second to seventh nu-
cleotide of the miRNA (18) and so the available software
may underestimate the impact of miRNA isoforms upon
target gene regulation.
There is good reason to believe that isomiRs are active in
vivo because they co-immunoprecipitate with Ago proteins
and are also active in luciferase and cleavage assays in vitro
(2,17,19–20). It is less clear how much isomiRs contribute
to the functional repertoire of a miRNA gene (16). There is
some evidence that isomiRs confer additional mRNA tar-
geting (21–23). Conversely, it has been cogently argued that
isomiRs and canonical miRNAs may generally target com-
mon mRNAs and that this is beneficial because of the ex-
pected reduction in off-target effects (20). It has proven dif-
ficult to determine the importance of isomiRs both because
of the limited tools that are available for modulating the lev-
els of specific isomiRs (16) and because of the overlapping
and redundant nature of most miRNA genes (24).
Here, we sequenced small RNAs from human embry-
onic stem cells (hESCs), neural stem cells (NSCs) and hu-
man mesenchymal stem cells (hMSCs). Analysis of the se-
quencing data shows that many miRNAs include isomiRs,
which were found to co-immunoprecipitate with endoge-
nous Argonaute protein and to be active in vitro, indicat-
ing that they are functional. We also found that the isomiR
to canononical miRNA proportion often differed between
cell and tissue types. Bioinformatic analysis predicts that 5′
isomiRs can target large numbers of mRNAs in addition
to the ones targeted by the canonical miRNA. In vitro lu-
ciferase assays validates these predictions andwe report that
an isomiR-9–1 has gained the ability to inhibit the expres-
sion of DNMT3B and NCAM2 but has lost the ability to
inhibit CDH1. We were able to use these differences in tar-
geting to construct sponges that were specific for miR-9 or
its 5′isomiR. We discuss that 5′isomiRs have frequently re-
placed miRNAs during evolution, which is supportive of
their functional and evolutionary importance.
MATERIALS AND METHODS
MicroRNA library cloning
sequencing for hMSCs miRNA library and Solexa sequenc-
ing for hESCs and NSCs miRNA libraries. A total of 500
g of total RNA was extracted from first trimester human
foetal MSC at passages 5–6 using Trizol (Invitrogen) and
∼10 g of total RNA of hESCs and NSC were enriched for
small RNAs using the miRVana kit (Ambion) according to
the manufacturer’s instructions. Polymerase chain reaction
(PCR) amplification and deep sequencing was performed as
specified by (25). Briefly, small RNAs were excised from a
15% 7M Urea polyacrylamide gel electrophoresis (PAGE)
and extracted with 0.3 M NaCl. RNAs were ligated to 5′
and 3′ adapters for PCR amplification using 454-forward
(5′-GCC TCC CTC GCG CCA TCA GCA GCC ATG
GGA ATT CCT CAC TAA-3′) and 454-reverse (5′-GCC
TTG CCA GCC CGC TCA GAC AGT CCA TGG ATT
G-3′) primers. PCR products were separated on a 10% na-
tive PAGE and the amplified ligation products were excised
and sequenced with 454 or Solexa technologies. TheH1 and
H1 neural microRNA libraries are deposited at NCBI SRA
submision numbers SRX547311 and SRX548700 and the
MSC data is deposited at NCBI GEO GSE58734.
Neural differentiation
Neural differentiation from hESC line H1 (WiCell) was
performed as described (26). Briefly, hESCs were split by
ethylenediaminetetraacetic acid (EDTA) (Ambion) and cul-
tured in N2B27 (1:1 mix of D-MEM/F12 supplemented
with N2 and Neurobasal medium supplemented with B27,
all from Gibco) with 100 ng/ml mouse recombinant nog-
gin (R&D Systems), on a matrigel (BD Biosciences) or
poly-L-lysine/Laminin (Sigma-Aldrich) coated plate. Sub-
sequently, cells were split using collagenase and cultured
in N2B27 and noggin. After about 3–4 weeks, cells were
split using TrypLETM (Gibco) and cultured in N2B27, sup-
plemented with 20 ng/ml basic fibroblast growth factor
(bFGF) (PeproTech).
Northern blotting
Total RNA (30–50 g) was separated on a 15% 7M Urea
PAGE and transferred to Hybond N+ (Amersham Bio-
sciences) membranes by semi-dry transfer for 30 min at
3.5 mA per cm2. Membranes were cross-linked at 1200
Joules/m2 and stored in the dark. MiRNA complemen-
tary probes were end-labelled with gamma-P32-adenosine
triphosphate using T4 polynucleotide kinase (New England
BioLabs). The membranes were hybridized at 42◦C with 7
ml of hybridization buffer (Denhardt’s, 0.1% sodium dode-
cyl sulphate (SDS), 2 × Saline sodium citrate (SSC)) for
a minimum of 2 h or overnight. Membranes were washed
twice at room temperature with 2 × SSC and 0.1% SDS
for 5 min and exposed on x-ray film with an intensifying
screen at −80◦C for a minimum of 48 h. Digoxigenin la-
belled locked nucleic acid probe (Exiqon) specific to miR-9,
miR-302a and let-7d were used in some of the hybridiza-
tion experiments.
Ago immunoprecipitation
Cells were lysed in 10 ml of lysis buffer (25 mM Tris-HCl,
150 mM KCl, 0.5% NP-40, 2 mM EDTA, 1 mM NaF, 0.5
mM DTT and 0.01% protease inhibitors) and centrifuged
at 10 000 x g for 10 min. The supernatant was incubated
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with 2 mls of Ago antibody hybridoma (13) rotating at
4◦C overnight. Subsequently 80 microlitres of sepharose G
beads were added to the supernatant for 1 h at 4◦C and the
beads were washed three times inwash buffer (300mMKCl,
50 mM Tris-HCl, 1 mMMgCl2 and 0.1% NP-40) and once
in phosphate buffered saline. RNA was extracted from the
beads with 1× volume of phenol and precipitated.
Construction of pGL3 luciferase––3′UTR constructs
The 3′UTRs of BTG1, CDH1, DNMT3B, Lefty1, PTEN
and Rock1 were amplified from human genomic DNA,
cloned into a pGEMT-easy vector and sequence verified.
pGEMT-easy vector containing the cloned 3′UTR was ex-
cised and ligated into XbaI and FseI sites at positions 1934
and 1953, respectively, of pGL3-Control vector (Promega,
E1741) to generate luciferase constructs with 3′UTR con-
taining specific microRNA seed target site. NCAM2 and
HMGA2 were ligated into pMIR-REPORT vector (Invit-
rogen) between SpeI and SacI sites at positions 525 and 519.
Primer sequences that were used to generate the UTRs by
PCR are listed in Supplementary Table S4, as are the pre-
dicted target sites and mutations that were made of some of
these sites.
Transfection and luciferase assay
A day prior to transfection, the HEK 293 cells were
split into single cells using trypsin-EDTA (Sigma-Aldrich)
and seeded at a density of 50 000 cells in a 24-well
plate containing DMEM supplemented with 10% FCS,
1% penicillin/streptomycin (Sigma-Aldrich) and 1% Glu-
tamine (Sigma-Aldrich). Transfection was performed the
next day, following the manufacturer’s protocol. In brief,
200–400 ng of reporter vector (pGL3, Promega; pMIR-
report, Invitrogen) and increasing concentration ofmiRNA
mimic miScipt from 1 to 20 nM (Qiagen) was added to 50
l of Opti-MEM, as well as 2 l of HiPerfect (Qiagen).This
mixture was incubated at room temperature for 20 min and
then added dropwise with gently mixing to the cells in 0.5
ml of freshly replaced media. The cells were incubated at
37◦Cwith 5%CO2. All experiments were performed in trip-
licates, and luciferase expression was measured at 48 h and
standardized to Renilla expression.
Microarray analysis
Overall messenger RNA expression and Ago2 associated
RNA was generated by microarray analysis using the
HumanWG-6V3 beadchip (Illumina Inc). The readings ob-
tained from the beadchip platform ranged from a signal of
61.70 to 63796.70; 67.10 to 65461 and 63.0 to 64372.7 (ar-
bitrary units) for hMSC, ESC and NSC, respectively. The
microarray data has been deposited here: http://www.ebi.ac.
uk/arrayexpress/experiments/E-TABM-1001/
Western blotting
Protein lysates were prepared from hESC and NSC cells
and 20 micrograms loaded per lane. Antibodies: Sox2
(ab97959, Abcam, 1;1000); Oct4 (sc5279, Santa Cruz,
1:500); Pax6(ab2237, Millipore, 1:700), -Actin (A5441,
Sigma, 1:5000).
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Figure 1. Changes in mRNA and microRNA expression during neural
differentiation from hESCs. (A)Morphological features during neural dif-
ferentiation. (B) Microarray analysis of ES and NS expression of pluripo-
tent and neural markers and confirmation by qRT-PCR and western blot-
ting. (C and D) Northern blotting and sequencing result comparison of
the indicated miRNAs during differentiation. (E) Detailed comparison of
northern and sequencing results for isomiRs of miR-9 (NSCs) and miR-
302a (ESCs). hESCs were differentiated to NSCs according to (26) and
cells were collected at four different stages of differention, i.e. hESCs (P0),
a week after neural induction (P1), 4 weeks after neural induction (P4)
and NSC at passages 40, 50 (NS50) and 60 (NS60). Total RNAs from
hESCs (PO) and NSCs (passage 40) were prepared for miRNA sequenc-
ing and microarray analysis. These samples and other NSC passages were
also analysed by northern blotting, qRT-PCR and western blotting. ESC,
embryonic stem cells; NSC, neuronal stem cells.
Generation of pcDNA3.1(+)-CDH1 and -DNMT3B sponges
Target sites of miR-9 within the 3′UTR of CDH1 and of
isomiR-9 within the 3′ UTR of DMN3TB DNA were used
to make sponges. DNA fragments consisting of 6 target site
repeats of miR-9 or isomiR-9 were synthesized by Eurogen-
tec andwere separately ligated into pcDNA3.1(+) under the
control of the cytomegalovirus promoter (see Supplemen-
tary Table S4 for sequence details).
RESULTS
MiRNAs from the same precursor have different 5′ and 3′
lengths
hESCs are derived from the inner cell mass of a blasto-
cyst and are able to divide indefinitely and to differenti-
ate along the ectoderm, mesoderm and endoderm lineages.
We induced hESC in vitro differentiation along the neu-
ral lineage with Noggin then bFGF and epidermal growth
factor (EGF) (Figure 1A) (26). Microarray analysis (Fig-
ure 1B, Supplementary Table S1) confirmed that differen-
tiation had occurred and as expected pluripotency markers
such as Oct4, Nanog and lin28Awere present in hESCs and
at the early stages of differentiation, while Nestin, which is
expressed mainly by nerve cells, was seen after differentia-
tion. Differentiation was also confirmed by quantitative re-
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verse transcriptase (RT)-PCR and western blotting (Figure
1B, Supplementary Table S1).
To investigate the role of miRNAs in this process, we
cloned and sequenced small RNA libraries from hESCs
prior to differentiation and from differentiated neural pro-
genitor stem cells (hNSCs) at passage 40. We also made a
miRNA library from hMSCs, see Materials and Methods.
Table 1 gives details of the libraries, the complete list of se-
quenced miRNAs are recorded in Supplementary Table S2.
There were striking differences in expression levels of many
miRNAs between hESC and derived NSCs, as well as hM-
SCs, these differences were confirmed by northern blotting
(Figure 1C and D). The northern blots also confirmed the
observation that most miRNA genes in our libraries pro-
duced isomiRs rather than a single miRNA product (Sup-
plementary Table S2). Figure 1E illustrates that the ratios of
the isomiR bands for miR-9 andmiR-302a that we detected
by northern blotting correspond well with the sequencing
results. About half of the miRNAs we sequenced had tem-
plate deletions or additions of bases at the 3′ end compared
to the most common miRNA sequence and a smaller but
substantial percentage had 5′ alterations (Figure 2A). A
greater percentage of 5′ end changes were confined to sin-
gle base additions or deletions compared to the 3′ end (Fig-
ure 2B), indicating that 5′ changes are under greater con-
straint. Figure 2C illustrates that minor changes at the 5′
ends of miR 9–1 and 302a have substantial impacts upon
their predicted targets. Overall, 31.2–46.4% of the predicted
targets of themost abundant 5′isomiRs in our three libraries
are not predicted targets of their canonical miRNAs and
only 22% of the predicted targets are, on average, in com-
mon between miRNA and isomiR pairs (Supplementary
Table S3).
Expression of isomiRs in cell lines and tissues
IsomiRs were readily detected in a variety of human cell
lines and mouse tissue types by northern blotting, confirm-
ing that isomiRs are commonly expressed in vivo (Figure 3).
The relative ratio of isomiRs encoded by the same miRNA
gene varied between cell types, for example, miR-151 and
27b show clear differences across human cell lines and the
isomiRs of let-7a and 221 differ across mouse organs (Fig-
ure 3A and B).
IsomiRs associate with Ago1 and Ago2
We tested whether isomiRs were associated with Argonaute
(Ago) proteins in vivo by comparing northern blotting re-
sults for isomiRs present in total RNA samples against
isomiRs that were first immunoprecipitated with antibod-
ies against Ago1 or Ago2. The results for all three cell types
hESC, hNSC and hMSC (Figure 3D, Supplementary Fig-
ure S1), show that isomiRs were co-immunoprecipitated
with either Ago1 or Ago2. As expected immunoprecipita-
tion with anti-alpha tubulin did not precipitate miRNAs
(Figure 3D) and we further confirmed specificity by show-
ing that a distinctive subset of mRNAs were co-precipitated
with anti-Ago from hMSCs (Supplementary Figure S1).
5′ and 3′ isomiRs are functional in vitro
In order to further test whether isomiRs are functional,
we constructed luciferase reporter vectors with the 3′UTR
mRNA of potential targets of miR-9, miR-302a, miR367
and their corresponding isomiRs (Supplementary Table
S4). We chose these miRNAs because they are among the
most abundant miRNAs expressed in hESCs (miR-302 and
367) or NSCs (miR-9–1) and because their isomiRs are
co-expressed at levels that are comparable to most of the
canonical miRNAs in our libraries (Supplementary Table
S2). There aremany predicted targets of thesemiRNAs (tar-
getscan) and their derived isomiRs (targetscan custom) and
Table 2 lists the targets that we chose on the basis of their
possible biological importance and also summarizes the re-
sults of our luciferase assays (Figure 4, and Supplementary
Figure S2).
The 3′UTR of PTEN is a predicted target of both hsa-
miR-367 and a common 3′ isomiR of 367 that we sequenced
in hESCs (Supplementary Table S2). Our titration shows
that the 3′ isomiR of hsa-miR-367 was an equally effective
inhibitor of PTEN as miR-367 (Figure 4A). We confirmed
that mutation of the predicted target site within the 3′UTR
of PTEN prevented repression by both miR-367 and the 3′
isomiR (Figure 4A,middle and bottom panels). By contrast
we were unable to confirm the prediction that BTG2 is a
target of miR-367 (Table 2, Supplementary Figure S2).
5′isomiRs can target different mRNAs
Figure 4B and C analyses two genes CDH1, which is a
known target of miR-9 (27) but is not a predicted target
of isomiR-9 and DNMT3B, which is a predicted target of
isomiR-9 but not of mir-9 (Table 2). We chose these two
genes because they are expressed in hESCs and are down-
regulated upon differentiation, which also corresponds with
the appearance of miR-9 and isomiR-9 (Figure 1B and
D). Luciferase assays confirmed that the 3′UTR of CDH1
is a target of miR-9, but our titration clearly shows that
isomiR-9 was not able to repress luciferase activity as ef-
ficiently (Figure 4B). By contrast, a similar titration exper-
iment shows that the 3′UTR of DNMT3B was a target of
isomiR-9 but notmiR-9 (Figure 4C). Our titrations indicate
that isomiR-9 is an equally good inhibitor of DNMT3B as
miR-9 is of CDH1. As a control we mutated two small re-
gions within the 3′UTRs of CDH1 and DNMT3B that are
the predicted binding sites for the seed regions ofmiR-9 and
isomiR-9, respectively, this markedly reduced luciferase in-
hibition in both cases (Figure 4B and C, middle and bottom
panels).
MiRNA sponges for isomiRs
In order to strengthen these results, we constructed two ex-
pression vectors that contain six repeated binding sites for
eithermiR-9 or isomiR-9. These binding sites have the same
sequence as the target sites within the 3′UTRs of CDH1
or DNMT3B (Figure 5A, Supplementary Table S4). The
first two column pairs of Figure 5B doubly repeat the ob-
servation that 12 nM miR-9 can inhibit the expression of
luciferase mRNA when it is fused to the 3′UTR of CDH1.
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Figure 2. The distribution of 5′ and 3′ isomiRs in hESCs, NSCs and MSCs. (A) A bar graph illustrating the percentage of isomiRs with 5′or 3′ changes
compared to the dominant miRNA for ESC, NSC and MSC miRNA libraries. (B) Additions and deletions at the 5′ and 3′ ends for ESC, NSC and MSC
miRNAs combined and expressed as a percentage. (C) Venn diagrams comparing the predicted targets of mir-9–1 and the most common 5′ isomiR-9 and
similarly for miR-302a. Predictions were made by TargetScanHuman (canonical) and TargetScan custom (isomiRs).
Table 1. Description of the miRNA sequencing libraries
Cell type Total reads No. of reads Unique reads No. of miRNAs*
(15–28 nuc) (15 – 28 nuc)
MSC 253 791 25 724 6043 95 454 Seq
ESC 1 697 514 1 276 916 24 534 92 Solexa
NSC 2 345 364 1 274 244 23 426 100 Solexa
*Sequenced more than five times. Unique reads: non-redundant, non-overlapping sequences reads.
The next two column pairs show that inhibition by 12 nM
miR-9 can be relieved by sufficient amounts of a miR-9
sponge (100 ng) but not by an isomiR-9 sponge (Figure 5B).
By contrast, Figure 5C shows that the isomiR-9 but not the
miR-9 sponge can relieve the inhibition of theDNMT3B lu-
ciferase expression vector by isomiR-9. Similarly, we iden-
tified NCAM2 as a target of isomiR-9 but not miR-9 and
also showed that repression by isomiR-9 could be rescued
by an isomiR-9 sponge (Supplementary Figure S2).
Overall, we confirmed predicted differences in targets be-
tween miRNA and 5′ isomiR pairs in three out of six cases
by luciferase assays (Table 2, rows 3, 4 and 5 versus rows 6,
7 and 8). There were two false negative and three false pos-
itive predictions, which are enclosed in brackets (Table 2).
In addition, the 3′UTRs of BTG1 and HMGA2 were con-
firmed as predicted targets of both miRNAs and 5′isomiRs
of miR-302a and miR-9, respectively.
5′ isomiR selection during evolution
We next asked whether 5′isomiRs have been selected during
evolution, as this would also indicate that isomiRs are of
functional importance. Figure 6A shows an example of two
paralogous human miRNA genes, hsa-mir-500a and 501,
together with the equivalent orthologous mouse miRNA
genes mmu-mir-500a and 501 (data from miRBase). It can
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Figure 3. Northern blot analysis of isomiRs in human cell lines and mouse tissues. (A) Human cell lines, (B and C) mouse tissues, (D) human ESC cells
before and after immunoprecipitation of Ago1 and Ago2. -tub, anti-alpha tubulin (negative control). A total of 20 ug of total RNA was loaded per lane.
Loading controls were stained with ethidium bromide.
be seen that the most common isomiR of hsa-mir-501, and
the twomouse miRNA genes (AUGCAC. . . . . . .) is a canon-
ical miRNA for hsa-mir-500a. This indicates that a canon-
ical miRNA may evolve as a result of increases in isomiR
frequency. The observation of 5′isomiR switching between
hsa-mir-500a and 501 (Figure 6A) is not simply a result of
inconsistent sequencing between different samples because
this result was extensively confirmed for single samples from
a wide range of tissues listed in miRGator (Supplemen-
tary Table S5). We found this one example of 5′isomiR
to miRNA switching between paralogous human miRNA
genes out of 140 gene cluster examples (28) that we screened
in both miRBase and miRGator (29,30).
In addition to hsa-mir-500a and mmu-mir-500, we found
two other examples of 5′isomiR to miRNA switching be-
tween 213 comparisons of human and mouse ortholo-
gous miRNA gene families (Figure 6B and C; data from
miRBase). These isomiR to miRNA switches are likely to
be equivalent to previous reports of seed shifts between
miRNAgenes from a variety of species (31,32) (Supplemen-
tary Figure S3; see Discussion).
We also asked to what extent the same miRNA gene
switches 5′isomiR expression between tissues. Figure 6D
gives an example of miR-215, in which a 5′isomiR
(UGACCU) is expressed as the dominant transcript by far
in liver and kidneys. We found four other convincing exam-
ples of 5′ isomiR switching (miR-101, 106a, 140 and 4454)
between human cell types out of a screen of 295 of the most
highly expressed miRNAs in miRGator (29) (Supplemen-
tary Table S5).
DISCUSSION
Over half of the miRNAs genes from our three stem cell li-
braries were expressed as isomers (isomiRs) that have 5′ or
3′ template differences compared to the dominant canonical
sequence (Figure 2A, Supplementary Table S2). The varia-
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Figure 4. 5′ and 3′ isomiR analysis in luciferase assays. (A) Top panel: the 3′UTR of PTEN was cloned into the luciferase vector pGL3 (Promega) and its
relative luciferase acitivity is plotted following its transfection (400 ng) into HEK293 cells with the indicated concentrations of miR-367 and a 3′ isomiR.
Middle panel: repeat luciferase assay followingmutation of the predicted seed target site formiR-367within the 3′UTRof PTEN. Bottom panel: illustration
of the sequences and expected alignment of miR-367 and isomiR-367 against the 3′UTRof PTEN. (B andC) Top panel: identical analyses of cloned regions
of the 3′UTR of CDH1, which has a predicted target site for miR-9 and for DNMTB3, which has a predicted target site for a 5′isomiR of miR-9. Middle
panels: repeat luciferase assays following mutation of the predicted seed target sites within the 3′UTRs. Bottom panel: illustration of the sequences and
expected alignments of miR-9 and 5′isomiR-9 against the 3′UTRs of CDH1 and DNMT3B. The 3′UTRs regions that were chosen and the seed target site
mutations are described in Supplementary Table S4. Error bars represent the standard deviation obtained from three independent experiments, * and **
represent statistical significance at the levels of P< 0.05 and P< 0.0001, respectively. Renilla luciferase was used as internal control to standardize against
all firefly luciferase activities. n = 3. Note for top panels B and C the statistical difference is between single columns for miR-9 and isomiR-9, whereas for
A the statistical difference is between the treatments and the control column pairs.
tion we detected is unlikely to be a cloning or sequencing
artefact because we observed similar variation in all cases
that were tested by northern blotting (Figures 1 and 3).
Previous miRNA sequencing projects report the presence
of isomiRs and similarly to our experiments demonstrated
their association with Ago proteins (2,17,20) (Figure 3). A
number of groups report that 3′ isomiR expression patterns
differ between cell lines or tissue types and in some cases
the changes are as much as 10-fold (33,34). Similarly, we ob-
served differences in isomiR expression between cell types
by northern blotting and by analysis of isomiR sequencing
databases (Figures 3 and 6).
The 5′ isomiR variants we sequenced occurred at a fre-
quency of only 5–15%, which is lower than the observed
3′isomiR variation of 40–50% between the three libraries
(Figure 2). However, 5′ isomiR variation is predicted to have
a major impact upon mRNA targeting, with an average of
only 22% of predicted targets in common between 5′isomiR
and miRNA pairs encoded by the same gene (Supplemen-
tary Table S3), which is reflective of the predictive weighting
given to the 5′ seed region of miRNAs for target recognition
(18). We used luciferase assays to confirm predicted differ-
ences between miRNA and isomiR pairs in three out of six
cases (Table 2). Our results therefore support the prediction
that single nucleotide changes at the 5′end of amiRNAhave
a substantial and easily measurable impact upon mRNA
targeting in vitro. We strengthened these results by showing
that it was possible to suppress the inhibitory effect of in-
dividual isomiRs in vitro through the use of isomiR-specific
sponge vectors (Figure 5). It is important to note that many
of the predicted mRNA targets of isomiRs are unique. For
example, isomiR-9 has 398 novel predicted targets com-
pared to miR-9 (Figure 2) and of these 18 are not predicted
targets of any other human miRNA. Consequently, isomiR
production increases the range of potential mRNA targets.
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Figure 5. Sponge inhibitors of miR-9 and isomiR-9. (A) Outline of sponge constructs pcDNA-miR-9 amd pcDNA-isomiR-9 (seeMaterials andMethods).
HEK293 cells were transfected with the indicated concentrations of each sponge vector with either (B) pGL3-CDH1–3′UTR (400 ng) and miR-9 (12 nM)
or (C) pGL3-DNMT3B-3′UTR (400 ng) and isomiR-9 (12 nM). All results were normalized by renilla luciferase. For sponge sequences see Supplementary
Table S4. Error bars represent the standard deviation obtained from three independent experiments, * represents statistical significance (between sponges)
at P < 0.05.
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A
hsa-miR-500a-3p          RPM hsa-miR-501-3p RPM
AAUGCACCUGGGCAAGGA....   24.2 AAUGCACCCGGGCAAGGA.... 31.1
AUGCACCUGGGCAAGGA....   56.5 AUGCACCCGGGCAAGGA.... 2.2
mmu-miR-500-3p mmu-miR-501-3p
AAUGCACCUGGGCAAGGG.... 222.5 AAUGCACCCGGGCAAGGA.... 163.2
AUGCACCUGGGCAAGGG.... 1.1 AUGCACCCGGGCAAGGA.... 2.2
B
hsa-miR-302c-3p mmu-miR-302c-3p
UAAGUGCUUCCAUGUUU..... 8950 CAAGUGCUUCCAGUUUU..... 0.4
AAGUGCUUCCAGUUUU..... 24 AAGUGCUUCCAGUUUU..... 6.9
C
hsa-miR-539-3p mmu-miR-539-3p
AUCAUACAAGGACAAUUU.... 71.7 AUCAUACAAGGACAAUUU.... 0.03
UCAUACAAGGACAAUUU.... 0.3 UCAUACAAGGACAAUUU.... 0.04
CAUACAAGGACAAUUU.... 9.0 CAUACAAGGACAAUUU.... 119.0
D
miR-215 Canonical miRNA IsomiR
AUGACCU….. UGACCU…… Samples QC let-7a-1 QC mir-23a
Lung 1 0.21 15 0.99 0.98
Mammary glandular cells 1 0.09 4 0.99 0.98
Liver 1 103 6 0.99 0.98
Kidney 1 11.8 3 0.99 0.98
Figure 6. IsomiR switching. (A) An example of 5′isomiR switching for hsa-mir-500a-3p. An isomiR of hsa-mir-501 (which is a paralogue of hsa-miR-500)
and the mouse gene orthologues mmu-mir-500 and 501 (AUGCACCC. . . ..) is expressed as a canonical miRNA by hsa-mir-500a. Only the most highly
sequenced isomiR and miRNA (lead strands) are shown for these genes, there are less common isomiRs for these genes that are not shown. RPM is
sequencing reads per million in total. The mir-500 family of miRNA genes are found only in mammals and in addition to Homo sapiens, the miR-500
genes of Gorilla gorilla, Sus scrofi and Canis familiaris also express AUGCACCU. . . . as the canonical miRNA. The remaining mammals for which there is
sequencing data (Mus musculus andRattus norvegicus) express AAUGCACCA . . . . as the canonical miRNA and AUGCACCA as an isomiR. For all other
members of the humanmiR-500 family (miR-500b, 501 and 502) AUGCACCU is expressed as an isomiR andAAUGCACCA . . . as the canonical miRNA.
(B) 5′isomiR to miRNA switch for mmu-mir-302c-3p. The miRNA AAGUGCUU. . . .. is expressed as a canonical miRNA by mmu-miR-302c but as an
isomiR by hsa-miR-302c and all of the remaining members of the miR-302 family of man and mouse. (C) An isomiR of hsa-mir-539 (CAUACAA. . . .) is
expressed as a canonical miRNA by mmu-mir-539 and by contrast an isomiR of mmu-mir-539 (AUCAUACAA. . . .) is expressed as the canonical miRNA
by hsa-mir-539. All data are taken frommiRBase release 19, (30) and confirmed inmiRGator v.3.0 for human sequences. In particular, miRGator confirmed
that the dominant transcript of hsa-mir-500a has a 5′ sequence AUGCACCC. . . .. in most cell types (29). (D) Table showing that hsa-mir-215 encodes an
isomiR (UGACCU) that is the dominant transcript in the liver and kidney. The miR-215 canoncial sequence (miRBase, (30)) is assigned a value of 1 for
each tissue type and the isomiR value equals the total number of isomiR sequence reads/total number of canonical sequencing reads for each tissue. Data
compiled from 15, 4, 6 and 3 sequencing reads from lung, mammary glandular cells, liver and kidney currently deposited in miRGator v3.0 (29). The last
two columns QC let-7a-1 and QC miR-23a are quality controls of the sequencing data. We analysed the invariant miRNAs let-7a-1 by dividing the total
number of sequencing reads for the canonical miRNA by the total number of sequencing reads. We similarly analysed has-miR-23a. This method can
identify samples that suffer from incomplete sequencing reads, see Supplementary Table S5 for further details.
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Table 2. Summary of the luciferase assay results for the targeting of the indicated 3′UTRs by the indicated miRNAs and isomiRs. The brackets mark
targetscan predictions that are discordant with the results.
No mRNA MiRNA Prediction Luc assay Notes
1 PTEN miR-367
√ √
New target
3′ isomiR-367
√ √
2 BTG2 miR-367 (
√
) X
3′isomiR-367 (
√
) X
3 CDH1 miR-9
√ √
Confirmation (ref)
5′ isomiR-9 X X (Ma et al., 2010)
4 DNMT3B miR-9 X X New target
5′ isomiR-9
√ √
5 NCAM2 miR-9 X X New target
5′ isomiR-9
√ √
6 HMGA2 miR-9
√ √
New target
5′ isomiR-9 (X)
√
7 BTG1 miR-302a
√ √
New target
5′ isomiR-302a (X)
√
8 Rock1 miR-302a X nt New target
5′ isomiR-302a (
√
) X
Our results extend a previous report that miR-133a and
a commonly sequenced 5′isomiR preferentially inhibit mR-
NAs encoded by Ctgf and PgamI, respectively, in luciferase
assays (23). Furthermore, it has also been noted that knock-
out of miR-223 in mouse neutrophils causes the depression
of some mRNAs that are not predicted targets of miR-223
but instead are predicted targets of a minor 5′isomiR that is
also expressed in this cell type (21). Overall, the available
evidence strongly indicates that 5′isomiRs are fully func-
tional in vivo. Our finding that some 5′isomiRs have become
canonical miRNAs during evolution or are the dominant
miRNA in certain tissues adds support to the more limited
evidence that isomiRs are also important (16).
Gene duplication or de novo hairpin formation is consid-
ered to be key to miRNA evolution as it provides an oppor-
tunity for new miRNA variants to evolve without destroy-
ing the tried and tested old variant (28,35). It has also been
suggested that new miRNAs are likely to be expressed at
low levels initially in order to avoid deleterious targeting ef-
fects and to allow the miRNA and selectively advantageous
mRNA targets to co-evolve (36). These criteria are bothmet
by initial low level production of isomiRs by single miRNA
genes. Figure 6 illustrates how minor isomiRs may become
canonical miRNAs during evolution and how gene duplica-
tion allows the retention of both old and new miRNA vari-
ants. Presumably a lot of the low level 5′isomiR variation
that is observed is not of physiological importance; however,
the observation that isomiRs may replace miRNAs during
evolution illustrates that some of the low level isomiR vari-
ation may acquire functionality in the future, as previously
argued for small RNA variation in general (36).
Our analysis supports the suggestion (28) that changes
in 5′isomiR usage during evolution are responsible for pre-
vious observations of seed shifting (31,32). Seed shifting
refers to miRNA transcripts that are encoded by ortholo-
gous or paralogous genes that have identical seed regions
at the DNA level yet produce miRNA transcripts that dif-
fer by small templated additions or deletions at the 5′end
of a miRNA transcript, presumably due to changes out-
side the encoded miRNA that affect processing. Wheeler
et al. (32) identified five such miRNA genes that in a mi-
nority of species express dominant miRNAs that have tem-
plated 5′ deletions or additions compared to the equivalent
miRNA transcripts expressed by most species. Similarly,
Marco et al., (31) identified examples of seed shifting by
comparing 46 orthologous miRNA genes from Drosophila
melanogaster and Tribolium castaneum. The more extensive
sequencing data that is now available shows that all of these
novel canonical miRNA transcripts that have seed shifts are
also found as 5′isomiRs in many species (Supplementary
Figure S3), indicating that seed shifting occurs through the
enhanced production of pre-existing 5′isomiR variants.
IsomiR switchingwould seem analogous tomiRNAarm-
strand switching, which has been documented to occur be-
tween paralogous and orthologous genes and between dif-
ferent tissue types (31,32). It is highly likely that strand
switching causes a substantial change in mRNA target-
ing (31), however, the effect of isomiR switching is less
clear. Cloonan et al. (20) observe that isomiR and canoni-
cal miRNA expression is usually highly correlated and they
provide evidence that this is because related isomiRs and
miRNAs tend to share similar targets. They also point out
that the targeting of a common mRNA by multiple miR-
NAs might be advantageous because of the expected reduc-
tion in off-target effects compared to targeting by a single
miRNA species. Similarly, only common targets of miR-
101 and a frequently expressed isomiR of miR-101 have
been identified, despite the fact that these two miRNAs,
show marked differences in expression between cell types
(37) (Supplementary Table S5). On the other hand, Fuku-
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naga et al., (22) report that only the longer form of two
5′isomiRs encoded by miR-307 can target the mRNAs for
glycerol kinase and taranis in Drosophila ovaries. Anlaysis
of the miRGator database indicates that a small percent-
age of humanmiRNA genes show substantial differences in
their miRNA to 5′isomiR ratios between different cell types
(Figure 6D; Supplementary Table S5), this percentage may
increase as further tissue specific sequencing data becomes
available. Our demonstration that it is possible to construct
sponges that are 5′isomiR specific should help to address
the question as to whether 5′isomiR switching between tis-
sues purposefully changes the targets of miRNA genes.
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